Nicole Murphy - Apr 1, 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Wendell Taylor, attorney in fact for Nicole Murphy
Stock symbol
BIIB
Transactions as of
Apr 1, 2024
Transactions value $
-$25,135
Form type
4
Date filed
4/3/2024, 08:11 PM
Previous filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +240 +2.52% $0.00 9.75K Apr 1, 2024 Direct F1
transaction BIIB Common Stock Tax liability -$25.1K -117 -1.2% $214.83 9.63K Apr 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -240 -100% $0.00* 0 Apr 1, 2024 Common Stock 240 $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/28/2024.
F2 This award was granted to the reporting person on April 1, 2021. The final portion of the awards vested on the third anniversary of the grant date.